REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
25/03/2021 12:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210325:nBw2BjZgka&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 24 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,773,781 1.38% 189,696 0.15%
(2) Derivatives (other than options):
102,935 0.08% 7,066 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,882,816 1.46% 202,862 0.16%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 221.7300 USD
Purchase 1 224.7600 USD
Purchase 1 224.3900 USD
Purchase 1 222.8700 USD
Purchase 3 224.8633 USD
Purchase 3 224.0266 USD
Purchase 3 223.9033 USD
Purchase 8 223.5875 USD
Purchase 10 223.7750 USD
Purchase 16 224.0800 USD
Purchase 27 223.8185 USD
Purchase 31 224.4864 USD
Purchase 40 224.4500 USD
Purchase 69 224.3444 USD
Purchase 100 223.9650 USD
Purchase 100 224.3600 USD
Purchase 100 224.5400 USD
Purchase 111 222.6980 USD
Purchase 123 221.2600 USD
Purchase 178 224.4676 USD
Purchase 300 224.2200 USD
Purchase 300 224.0433 USD
Purchase 300 223.8333 USD
Purchase 304 224.5139 USD
Purchase 369 224.1201 USD
Purchase 400 224.4162 USD
Purchase 500 224.1530 USD
Purchase 500 224.2920 USD
Purchase 581 224.4791 USD
Purchase 634 223.5849 USD
Purchase 700 224.4071 USD
Purchase 793 223.6267 USD
Purchase 843 224.3821 USD
Purchase 885 224.4404 USD
Purchase 1,056 223.9028 USD
Purchase 1,100 223.7563 USD
Purchase 1,319 224.4242 USD
Purchase 2,576 223.7453 USD
Purchase 2,588 223.9115 USD
Purchase 3,300 224.3180 USD
Purchase 3,317 223.8477 USD
Purchase 4,107 224.3200 USD
Purchase 9,987 223.2240 USD
Purchase 13,463 224.0620 USD
Purchase 17,039 224.2606 USD
Purchase 27,889 223.7400 USD
Sale 30 223.5900 USD
Sale 31 224.4864 USD
Sale 37 222.6980 USD
Sale 37 222.8000 USD
Sale 100 224.3600 USD
Sale 123 221.2600 USD
Sale 187 224.3655 USD
Sale 200 223.0600 USD
Sale 300 223.3313 USD
Sale 300 223.2500 USD
Sale 300 222.7383 USD
Sale 300 221.7566 USD
Sale 300 223.1333 USD
Sale 300 224.3000 USD
Sale 300 223.6500 USD
Sale 400 224.3875 USD
Sale 400 223.4612 USD
Sale 500 224.3240 USD
Sale 619 224.4208 USD
Sale 737 224.3403 USD
Sale 1,100 224.0500 USD
Sale 1,136 223.4907 USD
Sale 1,163 223.7405 USD
Sale 1,258 223.1816 USD
Sale 1,295 224.2529 USD
Sale 1,500 224.2631 USD
Sale 1,652 224.1882 USD
Sale 2,100 224.3059 USD
Sale 2,546 223.7471 USD
Sale 2,767 222.8900 USD
Sale 4,107 224.3200 USD
Sale 5,000 224.2924 USD
Sale 5,057 224.0658 USD
Sale 7,605 223.3908 USD
Sale 8,856 224.3527 USD
Sale 10,374 223.7400 USD
Sale 11,620 223.9040 USD
Sale 20,185 224.0040 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 25 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210325005514/en/
(https://www.businesswire.com/news/home/20210325005514/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
Announcement